| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2026―Jun―22 |
Expression features of miR-155 and miR-28 microRNAs in patients with long COVID and arterial hypertension |
N. U. Agzamxodjayeva, M. R. Ruzibakieva, D. E. Abidova, R. K. Islamova |
| 2 |
[GO] |
2026―Jun―22 |
Polymorphism in regulatory regions of the vascular endothelial growth factor gene (VEGF rs699947 and rs3025039) in former COVID-19 patients from Western Siberia |
A. V. Shevchenko, V. I. Konenkov, A. A. Karaseva, A. D. Afanaseva, I. I. Logvinenko |
| 3 |
[GO] |
2026―Feb―16 |
Changes in the molecular genetic profile of innate immune molecules in individuals who have had COVID-19 |
N. D. Abramova, N. O. Kalyuzhnaya, E. A. Meremianina, E. A. Bogdanova, M. P. Kostinova, O. A. Sviticha |
| 4 |
[GO] |
2025―Okt―20 |
Delta-Vac’ subunit vaccine induces strong humoral immune response against SARS-CoV-2 |
V. S. Nesmeyanova, Yu. A. Merkulyeva, A. A. Isaeva, N. V. Volkova, S. V. Belenkaya, M. B. Borgoyakova, et al. (+8) E. A. Volosnikova, T. I. Esina, E. D. Danilenko, A. V. Zaikovskaya, S. E. Olkin, O. V. Pyankov, A. A. Ilichev, D. N. Shcherbakov |
| 5 |
[GO] |
2025―Okt―20 |
Subpopulation profile of blood leukocytes in assessing severity of COVID-19 and in conditions associated with cytokine storm |
S. B. Putkov, N. V. Davydova, S. P. Kazakov |
| 6 |
[GO] |
2025―Okt―20 |
Prospectives of novel therapeutic and prophylactic medications based on symbiotic bacterial strains for correction of immune disorders mediated by intestinal microbiota in COVID-19 |
O. V. Bukharin, N. B. Perunova, T. Kh. Timokhina, E. G. Kostolomova, Ya. I. Paromova, E. V. Ivanova, et al. (+2) E. D. Polyanskih, A. A. Markov |
| 7 |
[GO] |
2025―Jun―09 |
Reinfection with SARS-CoV-2 variants: The issues of hybrid immunity efficiency |
I. A. Pobozhaya, N. M. Kalinina, N. V. Makarova |
| 8 |
[GO] |
2025―Mrz―11 |
Studying interconnections of cytokines and their diagnostic effectiveness when assessing severity grade in COVID-19 patients |
N. V. Davydova, S. B. Putkov, D. V. Reshetnyak, S. P. Kazakov |
| 9 |
[GO] |
2025―Mrz―11 |
The levels of SARS-CoV-2 IgG antibody and cytokine profile in blood serum of young people during the COVID-19 pandemic |
Yu. А. Li, M. N. Dmitrachenko, E. V. Markelova, M. P. Kostinov, I. B. Korolev, K. K. Nemtsev |
| 10 |
[GO] |
2025―Mrz―11 |
Humoral immunity in elderly persons vaccinated against influenza shortly before cancellation of COVID-19 pandemic |
S. V. Iushkova, M. P. Kostinov, L. S. Gladkova, A. A. Kameleva, A. S. Kachnova, A. M. Kostinova, et al. (+12) I. L. Solovyeva, N. P. Andreeva, Yu. A. Dagil, N. Yu. Nastaeva, N. O. Kryukova, K. A. Saifutdinov, A. V. Linok, I. A. Khrapunova, S. R. Raicic, M. N. Loktionova, V. B. Polishchuk, M. Y. Albahansa |
| 11 |
[GO] |
2025―Jan―23 |
Determination of t cell immune response to SARS-CoV-2 coronavirus based on induced γ-interferon production by specific T cells upon their stimulation by viral antigen |
B. S. Cherepovich, A. M. Kudryashova, L. L. Pankratieva, A. V. Bogolyubova, V. A. Manuilov, V. A. Gushchin, et al. (+3) A. A. Pochtovyi, O. V. Borisova, O. A. Svitich |
| 12 |
[GO] |
2025―Jan―23 |
Influenza vaccine is able to induce post-infection antibodies to SARS-CoV-2 in medical staff |
M. P. Kostinov, N. Yu. Nastaeva, N. F. Nikityuk, N. K. Akhmatova, M. I. Albahansa, S. V. Yushkova, et al. (+5) N. P. Andreeva, A. M. Kostinova, A. V. Linok, M. N. Loktionova, I. A. Khrapunova |
| 13 |
[GO] |
2024―Nov―08 |
Immune analysis of natural neurotropic autoantibodies in blood serum of patients with COVID-19 associated ischemic stroke |
Kh. A. Rasulova, M. A. Rasulova |
| 14 |
[GO] |
2024―Nov―08 |
Dynamics of humoral immunity during natural SARS-CoV-2 infection and/or after vaccination with the ‘Sputnik V’ vaccine |
A. V. Ivanov, M. A. Uvarova, K. B. Frolov, E. V. Semenova |
| 15 |
[GO] |
2024―Apr―22 |
Identification and functional characteristic of SARS-CoV-2-specific T lymphocytes in COVID-19 patients up to 16 months after disease onset |
I. S. Vladimirov, A. S. Zhdanova, V. E. Mukhin, V. V. Makarov, V. S. Yudin, S. A. Kraevoy |
| 16 |
[GO] |
2024―Apr―22 |
Purification technology design, biochemical and immunological characteristics of the recombinant chimeric antigen for evaluation of T cell immunity against coronavirus infection |
V. V. Kopat, A. A. Riabchenkova, E. L. Chirak, E. R. Chirak, A. I. Saenko, I. V. Kudryavtsev, et al. (+6) A. S. Trulioff, T. V. Savin, E. V. Zueva, A. S. Simbirtsev, A. A. Totolyan, I. V. Dukhovlinov |
| 17 |
[GO] |
2024―Apr―22 |
Pseudoneutralizing test for preclinical studies of vaccines against SARS-CoV-2 |
B. S. Cherepovich, A. M. Kudryashova, N. P. Kartashova, A. V. Gracheva, V. A. Manuilov, I. A. Leneva, et al. (+2) O. V. Borisova, O. A. Svitich |
| 18 |
[GO] |
2024―Feb―05 |
Correction of immune status from hospitalized COVID-19-patients with immunotropic drug added to the basic treatment |
E. A. Khromova, M. P. Kostinov, S. A. Skhodova, V. N. Osiptsov, I. V. Bisheva, D. V. Pakhomov, et al. (+4) E. A. Kurbatova, A. A. Khasanova, N. O. Kryukova, M. N. Shatokhin |
| 19 |
[GO] |
2024―Feb―05 |
Comparative characteristics of the cellular immune response to SARS-CoV-2 during infection and post-vaccination |
S. N. Klyueva, S. A. Bugorkova, A. L. Kravtsov, T. N. Kashtanova, V. A. Kozhevnikov |
| 20 |
[GO] |
2024―Jan―23 |
Systemic cytokines in elderly patients with coronary heart disease at early recovery from COVID-19 |
N. M. Agarkov, N. I. Zhernakova, V. A. Negrebetskiy |
| 21 |
[GO] |
2024―Jan―23 |
Some reflections on immunosuppressants and their delivery to the lungs by aerosol in the treatment of COVID-19 |
V. I. Kobylyansky |
| 22 |
[GO] |
2024―Jan―23 |
Role of Toll-like receptor gene polymorphism in pathogenesis of new coronavirus infection |
V. A. Beloglazov, I. A. Yatskov, A. A. Kamshiy, Yu. M. Agzamova |
| 23 |
[GO] |
2024―Jan―23 |
Comparison of different techniques for evaluation of cellular immunity to SARS-CoV-2 virus |
Z. E. Afridonova, A. P. Toptygina, A. V. Bogolyubova, E. L. Semikina |
| 24 |
[GO] |
2023―Jun―16 |
Patterns in the development of collective immunity to SARS-CoV-2 during the COVID-19 pandemic |
A. Yu. Popova, V. S. Smirnov, S. A. Egorova, I. V. Drozd, A. M. Milichkina, A. M. Dashkevich, et al. (+4) Z. S. Nurmatov, G. G. Melik-Andreasyan, M. M. Ruziev, Areg A. Totolian |
| 25 |
[GO] |
2023―Jun―16 |
Cholecalciferol as a means of nonspecific immunoprophylaxis against COVID-19 |
O. V. Berdiugina, E. Yu. Gusev |
| 26 |
[GO] |
2023―Jun―16 |
Characteristics of T-cell immunity and level of the natural killer cells content in COVID-19 convalescents with carbohydrate metabolism disorders |
K. S. Savchuk |
| 27 |
[GO] |
2023―Jun―16 |
Proinflammatory cytokines VEGFA, IL-6, IL-8 as markers of hepatotoxicity after COVID-19 |
M. A. Urevskii, L. V. Ilmukhina, Ya. E. Saranskaya, A. A. Lapshin, R. R. Gafurova |
| 28 |
[GO] |
2023―Jun―16 |
Features of the frequency of occurrence of T-330G <i>IL2</i> gene polymorphism in patients with COVID-19 |
E. S. Ageeva, R. N. Ablaeva, I. A. Yatskov, O. K. Aleshina, N. V. Rymarenko, V. A. Beloglazov, E. N. Dyadyura |
| 29 |
[GO] |
2023―Jun―16 |
MDC/CCL22 depletion in COVID-19 and post-COVID |
Z. R. Korobova, Areg A. Totolian |
| 30 |
[GO] |
2023―Jun―16 |
Cytokine diagnostics in the prognosis of critical conditions in newborns born to mothers infected with COVID-19 |
Sh. I. Navruzova, S. S. Baratov, Z. T. Nabieva |
| 31 |
[GO] |
2023―Jun―16 |
Pleiotropic immunomodulating effects of peptide Arginyl-alpha-Aspartyl-Lysyl-Valyl-Tyrosyl-Arginine on various subsets of neutrophilic granulocytes and their phenotype in patients with COVID-19 <i>in vitro</i> |
V. N. Gorodin, V. A. Matushkina, V. N. Chapurina, A. I. Menyailo, S. V. Kovaleva, E. I. Dydyshko |
| 32 |
[GO] |
2023―Jun―16 |
Preservation of the immunomodulatory effect of interval hypoxytherapy after coronavirus infection in the long-term period |
I. Kh. Borukaeva, Z. Kh. Abazova, A. B. Ivanov, I. A. Misirova, K. Yu. Shkhagumov, F. V. Shavaeva, et al. (+3) A. A. Mоlov, T. B. Kipkeeva, A. G. Shokueva |
| 33 |
[GO] |
2023―Feb―09 |
Interrelations between viral load and cellular immunity in patients with COVID-19 of varying severity |
Yu. V. Nikitin, E. V. Aleksandrova, A. B. Krivoruchko, M. E. Meshkova, L. V. Minaeva, K. V. Zhdanov, et al. (+7) A. A. Artamonov, K. V. Kozlov, A. M. Ivanov, O. V. Maltsev, K. S. Ivanov, Yu. I. Lyashenko, E. B. Masalov |
| 34 |
[GO] |
2023―Feb―09 |
Achievement of maximal SARS-CoV-2 collective immunity among the Tajik population by March 2022 |
A. Yu. Popova, V. S. Smirnov, S. A. Egorova, J. A. Abdullozoda, M. M. Ruziev, A. M. Milichkina, et al. (+13) V. A. Ivanov, S. D. Vokhidov, E. S. Ramsay, M. M. Mullodzhanova, I. V. Drozd, B. T. Holova, A. A. Krasnov, N. D. Jafarov, O. B. Zhimbaeva, A. V. Gubanova, A. P. Razumovskaya, V. G. Drobyshevskaya, A. A. Totolian |
| 35 |
[GO] |
2022―Nov―24 |
Субпопуляционный состав лимфоцитов периферической крови при COVID-19 |
Елена Викторовна Свирщевская, Мария Владимировна Коновалова, Валентин Фидаильевич Садыков, Алексей Викторович Пырегов, Римма Алексеевна Полтавцева |
| 36 |
[GO] |
2022―Nov―24 |
ИНТЕГРАЦИОННЫЙ ДИАГНОСТИЧЕСКИЙ КРИТЕРИЙ, ОЦЕНИВАЮЩИЙ ТЯЖЕСТЬ ТЕЧЕНИЯ COVID-19 И РИСК ВОЗНИКНОВЕНИЯ ПОСТКОВИДНОГО СИНДРОМА |
Ирина Вадимовна Нестерова, Маргарита Галимовна Атажахова, Валерия Александровна Матушкина, Юрий Валерьевич Тетерин, Владимир Николаевич Городин, Галина Анатольевна Чудилова |
| 37 |
[GO] |
2022―Nov―24 |
Особенности формирования поствакцинального гуморального иммунного ответа у перенесших COVID-19 разной степени тяжести |
Инна Александровна Иванова, Анна Филиппенко, Анастасия Труфанова, Наталья Омельченко, Ольга Чемисова, Алексей Носков |
| 38 |
[GO] |
2022―Nov―07 |
Effect of COVID-19 vaccination on the immune status and autoantibody profile in women of reproductive age |
A. A. Dovgan, Yu. S. Drapkina, N. V. Dolgushina, I. V. Menzhinskaya, E. V. Inviyaeva, V. V. Vtorushina, et al. (+2) L. V. Krechetova, G. T. Sukhikh |
| 39 |
[GO] |
2022―Nov―07 |
Role of IFNγ in pathogenesis of SARS-CoV-2 infection |
A. A. Artamonov, Yu. V. Nikitin, M. E. Meshkova, A. M. Ivanov |
| 40 |
[GO] |
2022―Jul―13 |
Mechanisms of formation of hybrid immunity in people who recovered from COVID-19 and were vaccinated with SARS-CoV-2 peptide antigens |
L. P. Sizyakina, I. I. Andrreeva, M. V. Kharitonova, N. S. Zaitseva, D. S. Lyubimov, V. Ya. Zakurskaya, Areg A. Totolian |
| 41 |
[GO] |
2022―Jul―13 |
Influence of SARS-CoV-2 variants’ spike glycoprotein and RNA-dependent RNA polymerase (nsp12) mutations on remdesivir docking residues |
Ali A. Dawood |
| 42 |
[GO] |
2022―Jul―11 |
Morphofunctional characteristics of blood cells in reconvalescents after suffering COVID-19 |
S. N. Klyueva, A. L. Kravtsov, S. A. Bugorkova |
| 43 |
[GO] |
2022―Jul―11 |
Identification of Surface Glycoprotein Mutations of SARS-CoV-2 in Isolated Strains from Iraq |
Ali A. Dawood, B. I. Jasim, O. Riadh Al-Jalily |
| 44 |
[GO] |
2022―Apr―25 |
Post-vaccination immunity phenotypes upon usage of EpiVacCorona vaccine in the persons who suffered COVID-19 |
L. P. Sizyakina, I. I. Andrreeva, M. V. Kharitonova, N. S. Zaitseva, D. S. Lyubimov, V. Ya. Zakurskaya, A. А. Totolian |
| 45 |
[GO] |
2022―Apr―25 |
Features of humoral immunity after COVID-19 |
E. V. Semenova, V. V. Pavliuk, M. A. Uvarova, A. V. Ivanov |
| 46 |
[GO] |
2022―Apr―25 |
Profile of antiphospholipid antibodies and complement system in COVID-19 patients of different severity |
N. V. Dolgushina, I. V. Menzhinskaya, O. S. Beznoshchenko, S. M. Mullabayeva, E. A. Gorodnova, L. V. Krechetova |
| 47 |
[GO] |
2022―Mrz―15 |
Lipopolysaccharide and ARDS caused by new coronavirus infection: hypotheses and facts |
I. A. Yatskov, V. A. Beloglazov, E. I. Ryapova |
| 48 |
[GO] |
2021―Dez―23 |
Role of the cellular immunity in the formation of the immune response in coronavirus infections |
I. A. Ivanova, N. D. Omelchenko, A. V. Filippenko, A. A. Trufanova, A. K. Noskov |
| 49 |
[GO] |
2021―Dez―23 |
Assessment of serological tests for antibodies to different antigens of the SARS-CoV-2 virus: comparison of six immunoassays |
V. V. Belyakova, O. A. Maiorova, N, V. Ivanova, I. E. Stepanova, M. A. Smerdova, et al. (+2) A. P. Obryadina, A. P. Toptygina |
| 50 |
[GO] |
2021―Nov―18 |
Proinflammatory status of oral fluid in COVID-19 |
I. A. Borodina, O. A. Gusyakova, I. A. Selezneva, F. N. Gilmiyarova, A. A. Ereshchenko, O. A. Baldina, et al. (+2) N. A. Kolotyeva, O. V. Borisova |
| 51 |
[GO] |
2021―Okt―19 |
COVID-19: OBSERVATIONS ON STANDARD TREATMENT ALGORITHMS |
I. Kh. Borukaeva, Z. Kh. Abazova, F. Kh. Temirzhanova, M. M. Yusupova |
| 52 |
[GO] |
2021―Jun―23 |
Distribution patterns of HLA-A*, B*, DRB1* allele groups among persons who underwent COVID-19 |
L. N. Bubnova, I. E. Pavlova, A. S. Berkos, M. A. Terentyeva, T. V. Glazanova, L. V. Erokhina, et al. (+8) E. V. Belyaeva, A. V. Chechetkin, N. S. Bashketova, I. G. Chkhindzheria, M. А. Kozhemyakina, D. V. Azarov, R. N. Kuznetsova, Areg A. Totolyan |
| 53 |
[GO] |
2021―Mai―03 |
Plasma cytokines in patients with COVID-19 during acute phase of the disease and following complete recovery |
N. A. Arsentieva, N. E. Liubimova, O. K. Batsunov, Z. R. Korobova, O. V. Stanevich, A. A. Lebedeva, et al. (+7) E. A. Vorobyov, S. V. Vorobyova, A. N. Kulikov, D. A. Lioznov, M. A. Sharapova, D. E. Pevtcov, A. A. Totolian |
| 54 |
[GO] |
2021―Jan―14 |
Two pandemics of the 21st century: COVID-19 and «swine flu» of 2009 |
T. N. Ilyicheva |
| 55 |
[GO] |
2020―Dez―01 |
COVID-19 therapy: from myths to reality and hopes |
S. V. Bozrova, M. S. Drutskaya, S. A. Nedospasov |
